NCT01616290View on ClinicalTrials.gov

Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2015

Conditions
Peripheral Artery Disease
Interventions
DRUG

PRT-201

0.03, 1, or 3 mg single adventitial administration

Trial Locations (2)

94121-9935

San Francisco VA Medical Center, San Francisco

94143-0957

University of California, San Francisco Medical Center, San Francisco

Sponsors
All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Proteon Therapeutics

INDUSTRY